TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. (TLSI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TLSI · as of Jun 8, 2026
Key Statistics
Explore TriSalus Life Sciences, Inc. Data
tlsi stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
The TLSI analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $8.00, representing +149.22% upside from the current price of $3.21.
Competitors & Peers
tlsi competitorsTLSI
ARMP
AVR
CATX
LNSR
MXCTStock Performance
Full HistoryAbout TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver an…
what is trisalus life sciences, inc. · tlsi stock overview · trisalus life sciences, inc. company profile · who is trisalus life sciences, inc. ceo · tlsi NASDAQ · trisalus life sciences, inc. headquarters · trisalus life sciences, inc. business segments
About Stock Overview & Key Data
TriSalus Life Sciences, Inc. (TLSI) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Feb 8, 2021. As of the latest trading session, TLSI stock price is $3.21, with a market capitalization of $121.7M. The stock has returned -42.58% over the past 12 months and -54.01% year-to-date.
According to 3 Wall Street analysts, the consensus rating for TriSalus Life Sciences, Inc. stock is Buy, with an average 12-month price target of $8.00. In fiscal year 2025, TriSalus Life Sciences, Inc. reported revenue of $45.2M and net income of -$39.2M. For detailed data — including TriSalus Life Sciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, TriSalus Life Sciences, Inc. (TLSI) stock price is $3.21. The stock is traded on NASDAQ under the ticker symbol TLSI. The 52-week range is $2.20 – $7.95.